1. Higher prevalence of HIV infection among people with disabilities: results of a population-based observational study in Yaoundé, Cameroon (HandiVIH)

De Beaudrap P, Beninguisse G,  Pasquier E, Tchoumkeu A, Touko A, Frida Essomba3, Brus A,  Aderemi T, Hanass-Hancock J, Henning Eide A, Mac-Seing M, Mont D.

En cours de révision

2. Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon – Trial ANRS-12286/MOBIDIP.

Galy A, Ciaffi L, Manirakiza Mberyo G, Mbouyap PR, Abessolo AH, Toby R, Essomba F, Lamarre G, Bikié A, Bell O, Koulla-Shiro S, Delaporte, E.

submitted

3. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second line maintenance treatment in HIV-1 infected patients in Sub Saharan Africa (ANRS12 286/MOBIDIP): a randomized, controlled, open-label superiority trial.

Ciaffi L, Koulla-Shiro S, Sawadogo A, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Ngom Gueye NF, Diallo M, Izard S, Bado G, Toure Kane C, Aghokeng A, et al. for the MOBIDIP Study Group.

Lancet HIV (Published online May 28, 2017 http://dx.doi.org/10.1016/S2352-3018(17)30069-3.

4. Firmin Nongodo Kabore, Sabrina Eymard-Duvernay, Jacques Zoungrana, Stephanie Badiou, Guillaume Bado, Arsène Hema, Assane Diouf, Eric Delaporte, Sinata Koulla-Shiro, Laura Ciaffi, Amandine Cournil. TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.

PLoS ONE, 2017, 12(11): e0186686. https://doi.org/10.1371/journal. pone.0186686

5. Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations.

Schmidt F, Liegeois F, Greenwood EJ, LeBreton M, Lester J, Deleplancque L, Peeters M, Aghokeng A, Tamoufe U, Diffo JL, Takuo JM, Wolfe ND, Leroy E, Rouet F, Heeney JL.

J Virol. 2017 Jan 11. pii: JVI.01884-16. doi: 10.1128/JVI.01884-16. [Epub ahead of print]

6. Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon.

Ndongo FA, Texier G, Penda CI, Tejiokem MC, Ndiang ST, Ndongo JA, Guemkam G, Sofeu CL, Kfutwah A, Faye A, Msellati P, Warszawski J; ANRS-PEDIACAM Study Group.

Pediatr Infect Dis J. 2017 Aug 23.

7. Prevalence of HIV infection among people with disabilities: a population-based observational study in Yaoundé, Cameroon (HandiVIH).

De Beaudrap P, Beninguisse G, Pasquier E. et al.

Lancet HIV 2017,4(4):e161-e168

8. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.

Kfutwah AK, Ngoupo PA, Sofeu CL, Ndongo FA, Guemkam G, Ndiang ST, Owona F, Penda IC, Tchendjou P, Rouzioux C, Warszawski J, Faye A, Tejiokem MC.

BMC Infect Dis. 2017 Mar 23;17(1):224.